In conclusion, it seemed that CAMK1 might be a promising biomarker for a better prognosis in PC patients, although the potential effect of CAMK1 expression on the biological function of PC and the reason for better prognosis remains to be further investigated. This evidence concerns the gene CAMK1 and pachyonychia congenita.